Bringing in health technology assessment and cost-effectiveness considerations at an early stage of drug development

Cost Effectiveness ofEML4-ALKFusion Testing and First-Line Crizotinib Treatment for Patients With AdvancedALK-Positive Non–Small-Cell Lung Cancer

(2014) Sandjar Djalalov et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

(2014) Nicholas R. Latimer et al.   MEDICAL DECISION MAKING

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methods for Adjusting for Bias Due to Crossover in Oncology Trials

(2014) K. Jack Ishak et al.   PHARMACOECONOMICS

The Role of Economic Evaluation in Meeting IOM’s Recommendations on Delivering High-Quality Cancer Care

(2014) Ya-Chen Tina Shih et al.   VALUE IN HEALTH

Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Health Technology Assessment

(2014) Michael Berntgen et al.   VALUE IN HEALTH

Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation

(2014) Linus Jönsson et al.   VALUE IN HEALTH

Survival Analysis for Economic Evaluations Alongside Clinical Trials—Extrapolation with Patient-Level Data

(2013) Nicholas R. Latimer   MEDICAL DECISION MAKING

EMA's parallel advice workshop bridges regulatory and reimbursement divide

(2013) Suzanne Elvidge   NATURE REVIEWS DRUG DISCOVERY

The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?

(2013) Michael S. Lauer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Progression-Free Survival: Meaningful or Simply Measurable?

(2012) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY

Principles for planning and conducting comparative effectiveness research

(2012) Bryan R Luce et al.   Journal of Comparative Effectiveness Research

PCN162 EXTRAPOLATION IN TRIAL-BASED COST-EFFECTIVENESS MODELING: IN SEARCH OF A STANDARD

(2011) M Ekman et al.   VALUE IN HEALTH